All posts by : Felistas

Creatine, the supplement popular with athletes for its ability to help build strength and power, is increasingly being recognized for its broad health benefits.

A compound found in the gut may reduce some of the manifestations of Alzheimer’s disease, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

Scientists have discovered a link between bacteria in the mouth and gut and the progression of cognitive decline in Parkinson’s disease. Specific changes in these bacteria, known as the microbiome, have been associated with cognitive decline in Parkinson’s. This includes the shift from mild memory issues to dementia, a common and distressing symptom of the disease.

One-size-fits-all hats are okay, but one-size-fits-all medical treatments don’t cut it. A new study shows that drug treatment outcomes are significantly different for a type of heart valve disease, called aortic valve stenosis, based on how the disease progresses in males versus females.

Ghana’s national agenda often focuses on the country’s large number of young people. In fact a less noticed demographic transformation is reshaping society: the country’s older population is growing rapidly. According to Ghana Statistical Service estimates, people aged 60 and above are projected to make up over 12% of the total population by 2050, more than doubling the 2021 estimate of 6.8%.

A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According to the National Brain Tumor Society, the average survival for patients diagnosed with glioblastoma is eight months.

A new study published in the Proceedings of the National Academy of Sciences presents a blood-based proteomic signature that predicts how long people are likely to live in good health—known as healthspan. The Healthspan Proteomic Score (HPS), developed by researchers at the UConn School of Medicine and collaborators at the University of Helsinki and the University of Exeter (UK), provides a powerful tool for understanding biological aging and assessing risks for a wide range of chronic diseases.

A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood.

Researchers from the University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological aging, even in their teenage years. The research, published online recently in Neurology, is the first to examine whether MS causes early aging in a pediatric population—offering new insight into the disease and its long-term progression.

UC Davis infectious diseases experts George Thompson and Angel Desai are raising the alarm about the role new pesticides can play in building resistance to antifungal medical treatments. In a commentary in the New England Journal of Medicine, they call for a coordinated, global “One Health” approach to developing, testing and using agents to fight pathogens like fungi and bacteria.